NASDAQ:PETX - Aratana Therapeutics News Headlines

$4.92
0.00 (0.00 %)
(As of 08/18/2019 04:00 PM ET)
Today's Range
$4.92
Now: $4.92
$4.92
50-Day Range
$4.92
MA: $4.99
$5.23
52-Week Range
$3.30
Now: $4.92
$7.16
VolumeN/A
Average Volume1.03 million shs
Market Capitalization$241.08 million
P/E RatioN/A
Dividend YieldN/A
Beta1.4

Headlines

Aratana Therapeutics (NASDAQ PETX) News Headlines

Source:
DateHeadline
Aratana Therapeutics Inc (NASDAQ:PETX) Receives Average Rating of "Hold" from AnalystsAratana Therapeutics Inc (NASDAQ:PETX) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - August 3 at 1:37 PM
Elanco Finalizes Acquisition of Aratana TherapeuticsElanco Finalizes Acquisition of Aratana Therapeutics
finance.yahoo.com - July 18 at 9:43 AM
Aratana shareholders back Elanco mergerAratana shareholders back Elanco merger
seekingalpha.com - July 16 at 6:22 PM
Aratana Therapeutics Stockholders Adopt Merger Agreement with Elanco Animal HealthAratana Therapeutics' Stockholders Adopt Merger Agreement with Elanco Animal Health
finance.yahoo.com - July 16 at 6:22 PM
Did Hedge Funds Drop The Ball On Aratana Therapeutics Inc (PETX)?Did Hedge Funds Drop The Ball On Aratana Therapeutics Inc (PETX)?
finance.yahoo.com - June 29 at 8:59 AM
CureVac Welcomes Two Members to its Supervisory BoardCureVac Welcomes Two Members to its Supervisory Board
finance.yahoo.com - June 24 at 4:54 PM
As Aratana awaits $245M sale closing, it wins fifth FDA approval in three yearsAs Aratana awaits $245M sale closing, it wins fifth FDA approval in three years
www.bizjournals.com - June 12 at 4:37 PM
The Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For AratanaThe Daily Biotech Pulse: Nuvectra Files For Expanded Label For Algovita SCS, Axovant Earnings, FDA Nod For Aratana
finance.yahoo.com - June 12 at 11:55 AM
Aratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL VialAratana Therapeutics Granted FDA Approval of NOCITA® (bupivacaine liposome injectable suspension) 10 mL Vial
finance.yahoo.com - June 11 at 6:25 PM
Aratana Therapeutics Reports Voting Results from 2019 Annual Meeting of StockholdersAratana Therapeutics Reports Voting Results from 2019 Annual Meeting of Stockholders
finance.yahoo.com - June 8 at 10:22 AM
AMBR, PETX Shareholder Class Actions: Halper Sadeh LLP Announces Shareholder Class Action Lawsuits Against Amber Road, Inc. and Aratana Therapeutics, Inc. – AMBR, PETXAMBR, PETX Shareholder Class Actions: Halper Sadeh LLP Announces Shareholder Class Action Lawsuits Against Amber Road, Inc. and Aratana Therapeutics, Inc. – AMBR, PETX
finance.yahoo.com - June 7 at 4:55 PM
Behind the scenes on Aratana’s sale to ElancoBehind the scenes on Aratana’s sale to Elanco
finance.yahoo.com - June 3 at 6:15 PM
Aratana Therapeutics (PETX) Presents At Stifel 2019 Dental & Veterinary Conference - SlideshowAratana Therapeutics (PETX) Presents At Stifel 2019 Dental & Veterinary Conference - Slideshow
seekingalpha.com - May 31 at 6:18 PM
16 Of The Most Interesting Deals16 Of The Most Interesting Deals
seekingalpha.com - May 22 at 9:04 AM
MERGER ALERT - PETX and SRMC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these CompaniesMERGER ALERT - PETX and SRMC: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
www.marketwatch.com - May 12 at 9:07 AM
PETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersPETX, KEYW, and ZAYO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
finance.yahoo.com - May 9 at 7:02 PM
Aratana (PETX) Reports Q1 Loss, Tops Revenue EstimatesAratana (PETX) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 9 at 9:08 AM
Aratana Therapeutics Reports First Quarter 2019 Financial ResultsAratana Therapeutics Reports First Quarter 2019 Financial Results
www.prnewswire.com - May 8 at 7:01 PM
Aratana Therapeutics to Present at Stifel 2019 Dental & Veterinary ConferenceAratana Therapeutics to Present at Stifel 2019 Dental & Veterinary Conference
finance.yahoo.com - May 7 at 6:23 PM
SHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc – PETXSHAREHOLDER UPDATE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc – PETX
finance.yahoo.com - May 6 at 7:02 PM
SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc – PETXSHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Aratana Therapeutics, Inc – PETX
finance.yahoo.com - May 6 at 9:09 AM
ARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETXARATANA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aratana Therapeutics - PETX
finance.yahoo.com - May 3 at 6:40 PM
Aratana (PETX) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseAratana (PETX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
finance.yahoo.com - May 1 at 6:51 PM
Elanco Animal Health And Aratana Therapeutics: Assessing The DealElanco Animal Health And Aratana Therapeutics: Assessing The Deal
seekingalpha.com - April 30 at 9:00 AM
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the FirmBragar Eagel & Squire, P.C. is Investigating the Board of Directors of Aratana Therapeutics, Inc. (PETX) on Behalf of Stockholders and Encourages PETX Investors to Contact the Firm
finance.yahoo.com - April 29 at 6:09 PM
ARATANA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of MergerARATANA THERAPEUTICS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger
finance.yahoo.com - April 27 at 9:10 AM
Aratana (PETX) Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Aratana Therapeutics, Inc. is Fair to Shareholders – PETXAratana (PETX) Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Aratana Therapeutics, Inc. is Fair to Shareholders – PETX
finance.yahoo.com - April 26 at 6:24 PM
Aratana up 32% premarket on Elanco takeoverAratana up 32% premarket on Elanco takeover
seekingalpha.com - April 26 at 9:06 AM
Aratana Therapeutics to be Acquired by Elanco Animal HealthAratana Therapeutics to be Acquired by Elanco Animal Health
finance.yahoo.com - April 26 at 9:06 AM
Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business FocusElanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus
finance.yahoo.com - April 26 at 9:06 AM
Animal health giant Elanco to acquire Aratana TherapeuticsAnimal health giant Elanco to acquire Aratana Therapeutics
finance.yahoo.com - April 26 at 9:06 AM
Aratana Therapeutics will sell for $245M to big animal health playerAratana Therapeutics will sell for $245M to big animal health player
finance.yahoo.com - April 26 at 9:06 AM
Aratana Therapeutics to Report First Quarter 2019 Financial ResultsAratana Therapeutics to Report First Quarter 2019 Financial Results
finance.yahoo.com - April 22 at 8:56 AM
Easy Come, Easy Go: How Aratana Therapeutics (NASDAQ:PETX) Shareholders Got Unlucky And Saw 77% Of Their Cash EvaporateEasy Come, Easy Go: How Aratana Therapeutics (NASDAQ:PETX) Shareholders Got Unlucky And Saw 77% Of Their Cash Evaporate
finance.yahoo.com - April 4 at 7:06 PM
Form 10-K ARATANA THERAPEUTICS, For: Dec 31 - StreetInsider.comForm 10-K ARATANA THERAPEUTICS, For: Dec 31 - StreetInsider.com
www.streetinsider.com - March 14 at 9:27 AM
CEO: Aratana is focused on near-term value enhancement, but R&D will continueCEO: Aratana is focused on 'near-term value enhancement,' but R&D will continue
www.bizjournals.com - March 13 at 6:30 PM
Aratana (PETX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo FinanceAratana (PETX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - March 13 at 11:03 AM
Aratana Therapeutics, Inc. (PETX) CEO Craig Tooman on Q4 2018 Results - Earnings Call Transcript - Seeking AlphaAratana Therapeutics, Inc. (PETX) CEO Craig Tooman on Q4 2018 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - March 13 at 11:03 AM
Edited Transcript of PETX earnings conference call or presentation 12-Mar-19 8:30pm GMTEdited Transcript of PETX earnings conference call or presentation 12-Mar-19 8:30pm GMT
finance.yahoo.com - March 13 at 11:03 AM
Aratana Therapeutics Inc (PETX) Q4 2018 Earnings Conference Call TranscriptAratana Therapeutics Inc (PETX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - March 12 at 8:15 PM
Aratana Therapeutics, Inc. (PETX)Aratana Therapeutics, Inc. (PETX)
finance.yahoo.com - March 12 at 8:04 PM
Aratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial ResultsAratana Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - March 12 at 8:04 PM
Aratana: 4Q Earnings SnapshotAratana: 4Q Earnings Snapshot
finance.yahoo.com - March 12 at 8:04 PM
Aratana (PETX) Reports Q4 Loss, Misses Revenue EstimatesAratana (PETX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 12 at 8:04 PM
Aratana Therapeutics, Inc. (NASDAQ:PETX): Are Analysts Optimistic?Aratana Therapeutics, Inc. (NASDAQ:PETX): Are Analysts Optimistic?
finance.yahoo.com - February 25 at 6:27 PM
Aratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial ResultsAratana Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - February 12 at 9:12 AM
New finance chief at Aratana TherapeuticsNew finance chief at Aratana Therapeutics
seekingalpha.com - February 4 at 10:47 AM
Aratana Therapeutics Appoints Rhonda Hellums Chief Financial OfficerAratana Therapeutics Appoints Rhonda Hellums Chief Financial Officer
finance.yahoo.com - February 4 at 10:47 AM
Aratana Therapeutics: A Dog Eat Dog WorldAratana Therapeutics: A Dog Eat Dog World
seekingalpha.com - January 26 at 8:54 AM
New VC fund in KC focuses on Animal Health Corridor - Kansas City Business JournalNew VC fund in KC focuses on Animal Health Corridor - Kansas City Business Journal
www.bizjournals.com - January 25 at 5:29 PM
This page was last updated on 8/18/2019 by MarketBeat.com Staff

Featured Article: What is the Rule of 72?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel